Creso Pharma Gears Up for Adult-Use Market with New Supply Agreement -- CFN Media
- Written by ACN Newswire
Canada's cannabis industry is projected to reach C$22.6 billion over the coming years, according to Deloitte analysts, driven by the legalization of adult-use cannabis in October of last year. While many licensed producers have been scaling up their production, the market continues to experience a shortfall in supply that has created an opportunity for investors in companies with near-term production coming online.
Please click here to receive an investor presentation and a going public alert https://promo.cfnmedia.com/cresopharma[1]
Canada's Supply Shortage
Canada legalized adult-use cannabis late last year, but many consumers haven't been able to partake. With persistent supply shortages, the government has been forced to shut down or delay the opening of many retail locations. Quebec's government-owned stores have been closed three days per week; Alberta has stopped issuing new retail licenses; and, Ontario will initially open just 25 stores in the country's most populated region.
Many cannabis executives believe that these supply shortages will persist. Auxly Cannabis Group Inc. CEO Chuck Rifici predicted that it could be at least three years before the market hits equilibrium. These sentiments were echoed by Organigram Holdings Inc. CEO Greg Engel and Valens GroWorks Corp. EVP Everett Knight, who both believe the supply shortage will last a couple of years or more.
These supply shortages are largely due to over optimistic projections from many licensed producers. In addition to failing to deliver, these rosy forecasts have caused a decline in the price of many LP stocks. Investors are concerned that LPs that have over promised on production could fail to meet their production, revenue, and profitability goals, while potentially compromising their relationships with the retail side of the industry.
TerrAscend Agreement
Creso Pharma is uniquely positioned to capitalize on these developments with its near-term production capacity. While many licensed producers have overcommitted, the company has strategically focused on building a diverse global enterprise with a commercial presence in both Canada and around the world. The company is one of just a handful of cannabis companies with existing commercial operations in Europe.
In January, the company signed a three-year supply agreement with TerrAscend Corp. to provide premium cannabis product to help meet the significant consumer demand following legalization in October. Creso Pharma committed to selling 100 kilograms of cannabis flower per month to TerrAscend.
The company recently completed a 24,000 sq. ft., purpose-built, state-of-the-art cultivation facility in Nova Scotia that's capable of producing more than 4,000 kilograms of cannabis per year. In addition to the new supply agreement, the company is in talks with the Nova Scotia Liquor Corp. to receive preferred placement at the government-run store due to its standing as one of just a handful of local producers.
VIDEO -- https://youtu.be/m8QMfb5-hzo[2]
Please click here to receive an investor presentation and a going public alert https://promo.cfnmedia.com/cresopharma[3]
Looking Ahead
Creso Pharma Ltd.(ASX: CPH) has quietly built a global cannabis enterprise with a portfolio of proprietary branded cannabidiol (CBD) products, including cannaQIX(R) and anibidiol(R), targeting both human and animal markets. With the potential for near-term Canadian production, the company is well positioned to scale into the tetrahydrocannabinol (THC) side of the business and capitalize on the under-supplied recreational market.
For more information, visit the company's website. https://www.cresopharma.com/[4]
Follow this link to read the full article: https://www.cannabisfn.com/2198774-2/[5]
About CFN Media
CFN Media (CannabisFN) is the leading agency and financial media network dedicated to the global cannabis industry, helps companies operating in the space attract investors, capital, and publicity. Since 2013, private and public cannabis companies in the US and Canada have relied on CFN Media to grow and succeed.
Learn how to become a CFN Media client company, brand or entrepreneur:http://www.cannabisfn.com/featuredcompany[6]
Download the CFN Media iOS mobile app to access the world of cannabis from the palm of your hand: https://itunes.apple.com/us/app/cannabisfn/id988009247?ls=1&mt=8[7]
Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your iPhone: http://www.cannabisfn.com[8]
DisclaimerCannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on http://www.cannabisfn.com[9] (the 'Site') is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news.
The above article is sponsored content. Emerging Growth LLC, which owns CannabisFN.com and CFN Media, has been hired to create awareness. Please follow the link below to view our full disclosure outlining our compensation: http://www.cannabisfn.com/legal-disclaimer/[10]
Frank Lane206-369-7050[email protected] [11]
Topic: Press release summarySectors: Daily Finance, BioTech, HealthCare, Alternatives, Local, Local Business[12][13][14][15][16][17] http://www.acnnewswire.com From the Asia Corporate News Network
Copyright © 2019 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.
References
- ^ https://promo.cfnmedia.com/cresopharma (promo.cfnmedia.com)
- ^ https://youtu.be/m8QMfb5-hzo (youtu.be)
- ^ https://promo.cfnmedia.com/cresopharma (promo.cfnmedia.com)
- ^ https://www.cresopharma.com/ (www.cresopharma.com)
- ^ https://www.cannabisfn.com/2198774-2/ (www.cannabisfn.com)
- ^ http://www.cannabisfn.com/featuredcompany (www.cannabisfn.com)
- ^ https://itunes.apple.com/us/app/cannabisfn/id988009247?ls=1&mt=8 (itunes.apple.com)
- ^ http://www.cannabisfn.com (www.cannabisfn.com)
- ^ http://www.cannabisfn.com (www.cannabisfn.com)
- ^ http://www.cannabisfn.com/legal-disclaimer/ (www.cannabisfn.com)
- ^ [email protected] (www.acnnewswire.com)
- ^ Daily Finance (www.acnnewswire.com)
- ^ BioTech (www.acnnewswire.com)
- ^ HealthCare (www.acnnewswire.com)
- ^ Alternatives (www.acnnewswire.com)
- ^ Local (www.acnnewswire.com)
- ^ Local Business (www.acnnewswire.com)
Authors: ACN Newswire
Read more http://www.acnnewswire.com/press-release/english/49257/
